After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter from the agency, but only for people 65 and older and those 12 and up who ...
A COVID-19 vaccine that could soon win federal authorization may offer a boost for the U.S. military: an opportunity to get shots into some of the thousands of service members who have refused the ...
Upfront and milestone payments offset weak COVID-19 vaccine demand CEO John Jacobs says licensing strategy insulates Novavax from policy uncertainty C. difficile vaccine candidate to enter trials by ...